The PennZone

  • Home
  • Non-profit
  • Books
  • Entertainment
  • Music
  • Marketing
  • Health
  • Legal
  • Technology

HandicapMD.com Expands Its Leading Telemedicine Service for Disabled Parking Placards in California
The PennZone/10282470

Trending...
  • UVIFY Brings Advanced Autonomous Systems Research to IROS 2026 in Pittsburgh
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Mad Darbarian is available for views as a Horror Host
HandicapMD
HandicapMD's video telehealth platform connects California state-licensed physicians to patients, offering quick, secure, and affordable online evaluations for disabled parking placards.

LOS ANGELES - PennZone -- HandicapMD, the nation's leading telemedicine platform for disabled parking permits, is expanding its services across California. Since its inception in 2022, HandicapMD has helped thousands of patients gain access to disabled parking permits in California, making the process easier and more efficient. Californians can now get evaluated by licensed physicians from the comfort of their own homes, with services starting at just $159.

California has one of the highest numbers of disabled individuals in the country, with over 4 million people utilizing disability benefits. Access to parking accommodations is a critical factor for many disabled individuals who rely on proximity to entrances and accessible spots for daily activities.

More on The PennZone
  • Turnstone Creative Welcomes Giovanni Amodei as Manager of Strategic Growth
  • CardsNearby Launches Free Nationwide Directory of Card Shows and Local Card Shops for Collectors
  • American Garden Rose Selections™ Announces 2027 Winners
  • Crossroads4Hope Launches Blood Cancer Resource Hub
  • Wilson Venture Capital to Launch News Organization; Will Name Trevor Wilson CEO

"We're proud to offer this vital online handicap placard service to the people of California," says Dr. Eric Jackson-Scott, CEO and Founder of HandicapMD. "Our platform ensures that individuals can secure their disabled parking permits without the hassle of in-person visits, long waits, or complicated paperwork. Our goal is to make the process as seamless and accessible as possible for everyone who qualifies."

In California, eligible patients can use their disabled parking placards to:
  • Park in designated disabled parking spaces
  • Avoid parking meter fees in some areas
  • Extend time limits in restricted parking zones
  • Access more convenient parking at key locations such as grocery stores, medical facilities, and more

With HandicapMD's easy-to-use telemedicine platform, no appointment is required, and evaluations are available seven days a week from 8 a.m. to 10 p.m. If a patient does not qualify for a disabled parking permit, they won't be charged for the evaluation.

More on The PennZone
  • NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
  • Georgia's Magical Nights of Lights Bigger and Brighter for 2026
  • Bicentennial Occult Outing Alternative History Video Series Launches for Spooky Season
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event

"We understand how important it is for individuals with disabilities to maintain their mobility and independence," says Dr. Jackson-Scott. "Our service not only helps those in need but does so with convenience and care, reflecting our commitment to improving accessibility in California."

About HandicapMD: HandicapMD is the leading telemedicine platform for disabled parking permits, serving patients across California and the United States. Since its launch, HandicapMD has provided thousands of patients with hassle-free access to certified doctors and streamlined the process of obtaining a disabled parking placard. HandicapMD is dedicated to simplifying healthcare solutions and empowering patients to live fuller, more independent lives.

For more information, visit handicap placards in California

Contact
Ena Doron
***@handicapmd.com


Source: HandicapMD

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • From Newcomers to Neighbors: LINC Celebrates the People Who Make the Valley Home
  • Lehigh Valley's Kellyn Featured in National Film Series Exploring the Future of Diabetes Care
  • Top 100 Golf Coach Daniel Guest and Imagen Golf Announce Partnership with Remo Golf at Fairways Golf Club
  • DBF Viewer 2000 v9.32 Adds New Control for Data Export
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Exonerated Movers Launches in Philadelphia on International Wrongful Conviction Day
  • Atlas Advisors President and Founder Mike McGuire Named a 2026 Leader in Business and Finance by LVB
  • Client 1st Financial Founder Michael Fischer Recognized for Building a Relationship-Rooted Career
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Curtis Salgado shares a love letter to the city of Chicago and Otis Rush with new single
  • Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
  • Names Are Not Important Asks What Remains When Identity Is Stripped of Labels
  • UVIFY Brings Advanced Autonomous Systems Research to IROS 2026 in Pittsburgh
  • Mad Darbarian is available for views as a Horror Host
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
  • Virtually Tour Heritage at South Brunswick's Resort-Style Living - Experience Indoor and Outdoor Amenities at Your Fingertips
  • Derek Cook's Roofing Encourages Homeowners to Prepare for Fall Weather
  • Boston Industrial Solutions Expands Product Offering with Pad Printing Pads and Silicone for Custom Pad Manufacturing
  • Rodeo FX Originals Appoints Yvann Thibaudeau Head of Development & IP
  • Phoenix 5/7 Emerges as a Genre-Fluid Artist Collective

Popular on PennZone

  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
  • Lake Norman Philharmonic - Free Community Concert
  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Garage door installation or repair in Minnesota? Which makes more sense for your family?
  • Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
  • A New Tale Band Makes 9/11 Tribute Song "The Twins" Free for Ceremonies and School Programs
  • New Bethany's 35th Annual Souper Day to Spotlight Connection Between Health, Hunger and Housing
  • The Culture and Travel Report Enters a New Chapter as Travel and Hospitality Brands Take Notice

Similar on PennZone

  • Pavillon 30 Years of Addiction Recovery in Western North Carolina, Earns National Accreditation
  • Ten Ten Ten Announces Maximizing Clinical Operations
  • Crossroads4Hope Launches Blood Cancer Resource Hub
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
  • Massage Revolution Expands to Santa Monica With New Wilshire Boulevard Location
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us